1H-Magnetic resonance spectroscopy for quantifying myocardial lipid content in humans with the cardiometabolic syndrome

Journal of Clinical Hypertension

Volumn 11, Issue 9, 2009, Pages 528-532

  O'Connor, Robert D ^a   Bashir, Adil ^a   Todd Cade, W ^a   Yarasheski, Kevin E ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FATTY ACID; LAMIVUDINE PLUS ZIDOVUDINE; LIPID; RITONAVIR;

ADULT; ARTICLE; CARDIOMETABOLIC SYNDROME; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL PROTOCOL; ELECTROCARDIOGRAM; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; HEART MUSCLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; LIPID ANALYSIS; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; TISSUE LEVEL; BLOOD; CHEMISTRY; DYSLIPIDEMIA; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; MYOCARDIUM; SENSITIVITY AND SPECIFICITY;

EID: 70349973719     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1559-4572.2009.00061.x     Document Type: Article

References (23)

1. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002, 106:3143-3421.
2. Grundy SM, Brewer HB, Cleeman JI. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109:433-438.
3. Kankäänpä M, Lehto H-R, Pärkkä JP. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrin Metab 2006, 91:4689-4695.
4. Zhou Y, Grayburn P, Karim A. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000, 97:1784-1789.
5. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrin Metab 2004, 89:2595-2600.
6. Boesch C, Machann J, Vermathen P. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 2006, 19:968-988.
7. McGavock JM, Lingvay I, Zib I. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007, 116:1170-1175.
8. Berstein MA, King KF, Zhow XJ. Handbook of MRI Pulse Sequences 2004, 1st edn, Burlington, MA, Elsevier Academic Press
9. Levitt MH, Madhu PK, Hughes CE. Cogwheel phase cycling. J Magn Reson 2002, 155:300-306.
10. O'Connor RD, Gropler RJ, Peterson L. Limits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol. J Pharm Biomed Anal 2007, 45:382-389.
11. Xu J. MRS with Free-breathing 2D-PACE (WIP) [computer program] 2006, Version 1.0, New York, NY, Siemens Medical Solutions USA Inc.
12. Naressi A, Couturier C, Devos JM. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001, 12:141-152.
13. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior-knowledge. J Magn Reson 1997, 129:35-43.
14. Andersson A. Fatty Acid Composition in Skeletal Muscle. Influence of Physical Activity and Dietary Fat Quality [Doctor of Philosophy] 2001, Uppsala, Faculty of Medicine, Uppsala University
15. Reingold JS, McGavock JM, Kaka S. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 2005, 289:E935-E939.
16. Mannina L, Sobolev AP, Segre A. Olive oil as seen by NMR and chemometrics. Spectrosc Eur 2003, 15:6-14.
17. Szczepaniak LS, Babcock EE, Schick F. Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 1999, 276:E977-E989.
18. Szczepaniak LS, Dobbins RL, Metzger GJ. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003, 49:417-423.
19. vd Meer RW, Skozerke S, Doornbos J. Respiratory navigator gated 1H-MR spectroscopy of the human heart to assess myocardial triglyceride content: a study on reproducibility. J Cardiovasc Magn Reson 2006, 8:102-103.
20. Definitions and Terminology Paper presented at: FDA International Conference on Harmonization Guide Lines on Validation of Analytical Procedures, March 1995, Rockland, MD, FDA
21. Lenth RV. Java Applets for Power and Sample Size [computer program] http://www.stat.uiowa.edu/~rlenth/Power, Version 3.0, . Accessed July 30, 2008
22. Aetna. May 2 2006. 0202
23. Serum Triglyceride Determination Kit, TR0100, Sigma-Aldrich, St. Louis, MO 63103